.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PATANOL Drug Profile

« Back to Dashboard
Patanol is a drug marketed by Alcon and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has twenty-three patent family members in nineteen countries.

The generic ingredient in PATANOL is olopatadine hydrochloride. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the olopatadine hydrochloride profile page.

Summary for Tradename: PATANOL

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Drug Prices: :see details

Pharmacology for Tradename: PATANOL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
PATANOL
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 1996RXYes5,641,805*PED► subscribe ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PATANOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon
PATANOL
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 19964,871,865► subscribe
Alcon
PATANOL
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 19965,641,805*PED► subscribe
Alcon
PATANOL
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 19965,116,863*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PATANOL

Drugname Dosage Strength RLD Submissiondate
olopatadine hydrochlorideOphthalmic Solution0.10%Patanol7/17/2006

International Patent Family for Tradename: PATANOL

Country Document Number Estimated Expiration
Luxembourg90969► subscribe
Denmark0799044► subscribe
Germany69622527► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PATANOL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0040France► subscribePRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517
2002 00029Denmark► subscribe
C029/2002Ireland► subscribeSPC029/2002: 20040930, EXPIRES: 20170516
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc